SYNTIS BIO Trademark

Trademark Overview


On Friday, June 20, 2025, a trademark application was filed for SYNTIS BIO with the United States Patent and Trademark Office. The USPTO has given the SYNTIS BIO trademark a serial number of 99245108. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 3, 2026. This trademark is owned by Syntis Bio, Inc.. The SYNTIS BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders, namely, Alzheimer's Disease, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver disease...

General Information


Serial Number99245108
Word MarkSYNTIS BIO
Filing DateFriday, June 20, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders, namely, Alzheimer's Disease, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Pharmaceutical preparations for the treatment and prevention of chronic metabolic diseases, metabolic conditions, and functional neurological disorders; Biological preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
NOT AVAILABLEBIO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSyntis Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02125
US

Party NameSyntis Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02125
US

Trademark Events


Event DateEvent Description
Friday, June 20, 2025NEW APPLICATION ENTERED
Friday, June 20, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 20, 2025APPLICATION FILING RECEIPT MAILED
Monday, November 10, 2025ASSIGNED TO EXAMINER
Monday, November 10, 2025NON-FINAL ACTION WRITTEN
Monday, November 10, 2025NON-FINAL ACTION E-MAILED
Monday, November 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 25, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 3, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 3, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED